ABBV ▲ +0.6% - AbbVie Inc.
$ABBV - Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
05-OCT-2026 03:00 PM ET
Share this post
More filings for $ABBV
ABBV ▲ +0.6% - AbbVie Inc.Oct 5, 2026ABBV ▼ -0.1% - AbbVie Inc.Oct 1, 2026ABBV ▼ -0.0% - AbbVie Inc.Oct 1, 2026ABBV ▼ -1.2% - AbbVie Inc.Sep 30, 2026ABBV ▼ -1.2% - AbbVie Inc.Sep 30, 2026ABBV ▼ -0.2% - AbbVie Inc.Sep 22, 2026
View full $ABBV filing history →💬 Comments
Loading comments…
Leave a comment